Cargando…

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy

The aim of this study was to elucidate the correlation between m6A modification and the tumor immune microenvironment (TIME) in prostate cancer (PCa) and to identify the m6A regulation patterns suitable for immune checkpoint inhibitors (ICIs) therapy. We evaluated the m6A regulation patterns of PCa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zezhen, Zhong, Jiehui, Zeng, Jie, Duan, Xiaolu, Lu, Jianming, Sun, Xinyuan, Liu, Qinwei, Liang, Yingke, Lin, Zhuoyuan, Zhong, Weide, Wu, Wenzheng, Cai, Chao, Zeng, Guohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438522/ https://www.ncbi.nlm.nih.gov/pubmed/34531875 http://dx.doi.org/10.3389/fimmu.2021.735170

Ejemplares similares

Immune-related biomarker risk score predicts prognosis in prostate cancer
por: Liu, Zezhen, et al.
Publicado: (2020)

A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer
por: Lu, Jianming, et al.
Publicado: (2023)

m(6)A modification patterns and tumor immune landscape in clear cell renal carcinoma
por: Zhong, Jiehui, et al.
Publicado: (2021)

miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2018)

[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2023)

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
por: Zeng, Jie, et al.
Publicado: (2023)

Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
por: Liu, Jie, et al.
Publicado: (2022)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

Immunotherapy of targeting MDSCs in tumor microenvironment
por: Sui, Hongshu, et al.
Publicado: (2022)

Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer
por: Guo, Yongdong, et al.
Publicado: (2021)

Immunotherapy: Reshape the Tumor Immune Microenvironment
por: LV, Bingzhe, et al.
Publicado: (2022)

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer
por: Cai, Zhiduan, et al.
Publicado: (2020)

Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy
por: Wang, Jin, et al.
Publicado: (2022)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses
por: Deng, Ruiyi, et al.
Publicado: (2022)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma
por: Nan, Han, et al.
Publicado: (2023)

Vascular Microenvironment, Tumor Immunity and Immunotherapy
por: Lamplugh, Zachary, et al.
Publicado: (2021)

The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022)

Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
por: Yan, Dongming, et al.
Publicado: (2022)

Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy
por: Lin, Enyu, et al.
Publicado: (2022)

Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods
por: He, Zihao, et al.
Publicado: (2019)

Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies
por: Tan, Xiao, et al.
Publicado: (2023)

Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer
por: Yu, Guopeng, et al.
Publicado: (2022)

Knowledge mapping and current trends of immunotherapy for prostate cancer: A bibliometric study
por: Zhong, Weibo, et al.
Publicado: (2022)

Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy
por: Zhao, Zi-Yue, et al.
Publicado: (2022)

Characterization of Fatty Acid Metabolism-Related Genes Landscape for Predicting Prognosis and Aiding Immunotherapy in Glioma Patients
por: Jiang, Feng, et al.
Publicado: (2022)

A Novel PD-L1-Containing MSLN Targeting Vaccine for Lung Cancer Immunotherapy
por: Zeng, Wuyi, et al.
Publicado: (2022)

Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer
por: Xu, Ximo, et al.
Publicado: (2023)

Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2022)

Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy
por: Qiu, Qin, et al.
Publicado: (2021)

Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
por: Oliver, Amanda J., et al.
Publicado: (2018)

Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
por: Ngiow, Shin Foong, et al.
Publicado: (2020)

The role of lncRNAs in the tumor microenvironment and immunotherapy of melanoma
por: Zhou, Wencheng, et al.
Publicado: (2022)

Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy
por: Yang, Rou, et al.
Publicado: (2023)

Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy
por: Zhong, Kaihang, et al.
Publicado: (2022)

Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy
por: Han, Ye, et al.
Publicado: (2022)

Cuproptosis depicts tumor microenvironment phenotypes and predicts precision immunotherapy and prognosis in bladder carcinoma
por: Li, Huihuang, et al.
Publicado: (2022)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
por: Liu, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8oc827jlve7tturleso9hq601